TIMOTHY J BARBERICH
CIK 1120355 · Executive Chairman · last filed 2023-12-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$187.3K
Companies
8
Total Filings
85
Lifetime Open-Market Net
-$33.24M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TCRX | Director | 99,969 | $0.77 | $76.8K | $242.0K | 5 | 2023-12-21 |
| Korro Bio, Inc. (FREQ) Delisted | Director | 3,655 | $14.98 | $54.8K | $0 | 5 | 2022-08-19 |
| VSTM | Director | 18,167 | $6.08 | $110.5K | $813.6K | 13 | 2021-06-30 |
| ROCKET PHARMACEUTICALS, INC. (ITEK) Delisted | Director | — | — | — | $0 | 2 | 2017-06-21 |
| HeartWare International, Inc. (HTWR) Delisted | Director | 0 | — | — | $195.5K | 17 | 2016-08-24 |
| Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Director | 13,453 | — | — | $0 | 3 | 2016-06-16 |
| BIOSPHERE MEDICAL INC (BSMD) Delisted | Director | 0 | — | — | $0 | 6 | 2010-09-10 |
| SEPRACOR INC /DE/ (SEPR) Delisted | Director | 526,598 | — | — | -$34.49M | 29 | 2009-10-19 |
Recent Filings · Page 2 of 9
85 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-18 | VSTM | Grant (A) | — | $0 | EDGAR |
| 2020-06-12 | Korro Bio, Inc. (FREQ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-18 | — | Grant (A) | — | $0 | |
| 2019-10-07 | Korro Bio, Inc. (FREQ) Delisted | Conv (C) | +165,272 | $0 | EDGAR |
| 2019-06-25 | VSTM | Grant (A) | — | $0 | EDGAR |
| 2019-03-19 | VSTM | Buy (P) | +33,000 | $105.9K | EDGAR |
| 2018-10-02 | VSTM | Buy (P) | +5,000 | $36.5K | EDGAR |
| 2017-12-07 | VSTM | Buy (P) | +60,538 | $239.1K | EDGAR |
| 2017-06-21 | ROCKET PHARMACEUTICALS, INC. (ITEK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-15 | VSTM | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.